Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	GEn Placebo	41
Overall Study	STARTED	GEn 600 mg	48
Overall Study	STARTED	GEn 1200 mg	45
Overall Study	STARTED	GEn 1800 mg	38
Overall Study	STARTED	GEn 2400 mg	45
Overall Study	COMPLETED	GEn Placebo	31
Overall Study	COMPLETED	GEn 600 mg	34
Overall Study	COMPLETED	GEn 1200 mg	31
Overall Study	COMPLETED	GEn 1800 mg	30
Overall Study	COMPLETED	GEn 2400 mg	33
Overall Study	NOT COMPLETED	GEn Placebo	10
Overall Study	NOT COMPLETED	GEn 600 mg	14
Overall Study	NOT COMPLETED	GEn 1200 mg	14
Overall Study	NOT COMPLETED	GEn 1800 mg	8
Overall Study	NOT COMPLETED	GEn 2400 mg	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01332305/flow